CoreTissue BioEngineering Inc. ("CTBE"), a medical device start-up (Headquarters: Yokohama City, Kanagawa Prefecture, CEO: Yoji Jokura, Ph.D.) announces that the safety evaluation in the safety cohort ...
Scientists have developed a breakthrough injectable biomaterial that travels through the bloodstream to repair damaged tissue ...
Norwegian startup ClexBio is bioengineering human veins to implant inside a patient’s body. Together with CSEM, a Swiss R&D centre, the company has built a prototype bioreactor to grow the veins.
Biological tissues have a remarkable ability to organize and change shape, driven by forces generated by their own cells. One of the major challenges in bioengineering is harnessing this natural ...
Researchers from MIT have developed a 3D-printable tissue adhesive that demonstrates superior tissue adhesion, rapid sealing capabilities across various surgical scenarios and a unique blood-repelling ...
YOKOHAMA, Japan--(BUSINESS WIRE)--CoreTissue BioEngineering Inc. (“CTBE”), a medical device start-up developing an artificial ligament derived from decellularized animal tissue, is the first company ...
D bioprinted human skin model; modular ultrasound training systems; and device for newborns with abdominal wall defects—are ...
From lab benches to real-world impact, bioengineering is transforming healthcare through innovative research, student-led projects, and groundbreaking tissue engineering methods. Universities and ...
An implantable tissue flap containing muscle and fat alongside a hierarchical network of blood and lymphatic vessels could offer hope for patients with severe tissue damage. An international research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results